Genetic Modifications to Alter Blood Pressure Level.

Area of Science:

• Genetics
• Cardiovascular Biology
• Molecular Biology

Background:

• Genetic manipulation is essential for studying gene function in vitro and in vivo.
• Cardiovascular phenotypes like blood pressure require in vivo models.
• Genome-wide association studies (GWAS) have identified genetic variations linked to hypertension, but causal links are often unclear.

Purpose of the Study:

• To highlight the necessity of creating genetically modified animal models for functional gene analysis.
• To emphasize the role of genome editing in validating genetic risk variants for complex diseases like hypertension.
• To bridge the gap between GWAS findings and understanding disease pathophysiology.

Main Methods:

• Creation of transgenic, knock-out, and knock-in experimental animals.
• Application of genome-editing technologies (e.g., CRISPR-Cas9) in various cell types and organisms.
• Utilizing these models to study gene function and disease mechanisms.

Main Results:

• Transgenic and gene-targeted animal models enable the study of cardiovascular phenotypes.
• Genome editing facilitates the precise creation of knock-out/knock-in models.
• These models are instrumental in validating the pathophysiological roles of candidate genes and risk variants.

Conclusions:

• Genetic manipulation in animal models is indispensable for understanding gene function, especially for cardiovascular traits.
• Genome editing provides a powerful tool to create precise genetic models for disease research.
• Validating GWAS-identified risk variants through genome-edited organisms is a critical next step in understanding hypertension and related conditions.